Related Experiment Video
Updated: Aug 13, 2026

Protocol for Plasmodium falciparum Infections in Mosquitoes and Infection Phenotype Determination
Published on: July 4, 2007
The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme
C Girmenia1, L Pagano, L Corvatta
1Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy. girmenia@bce.med.uniroma1.it
Abstract:
Fusariosis has been considered an emerging infection in patients with haematological malignancies. In a multicentre retrospective study on filamentous fungi infections in patients with haematological diseases over a period of 10 years in Italy, fusariosis was documented in six patients from two of the 14 centres with a 0.06% incidence in acute leukaemia. A literature search yielded 177 cases of Fusarium infections in haematological diseases and acute leukaemia accounted for 71% of the underlying conditions. An increase from 0.5 to 3.8 cases per year was observed at the M.D. Anderson Cancer Center of Houston in the periods 1975-85 and 1986-95 respectively. Conversely, only 5.1 and 6.3 cases per year have been reported in the periods 1981-90 and 1991-96, respectively, from the other centres in the world. Half of the cases have been observed in the USA. In Europe, most of the cases have been observed in France and Italy. Invasive fusariosis is a rare complication in haematological diseases, as its overall frequency does not seem to be significantly increased within the last 20 years. However, its epidemiological distribution is not homogeneous and the possibility of local clusters of infections by this deadly pathogen should be carefully considered.
Insights
Fusariosis, a fungal infection, is rare in patients with blood cancers. While not increasing overall, its geographic distribution is uneven, necessitating awareness of potential local outbreaks.
Area of Science:
- Medical Mycology
- Hematology
- Infectious Diseases
Background:
- Fusariosis is an emerging infection in patients with hematological malignancies.
- Filamentous fungi infections, including fusariosis, pose a risk to immunocompromised individuals.
Purpose of the Study:
- To investigate the incidence and epidemiology of fusariosis in patients with hematological diseases.
- To analyze trends in Fusarium infections over a 10-year period in Italy and globally.
Main Methods:
- Multicenter retrospective study of filamentous fungi infections in Italian hematology centers (10-year period).
- Comprehensive literature search for Fusarium infections in hematological diseases.
- Analysis of incidence data from M.D. Anderson Cancer Center and global centers.
Main Results:
- Fusariosis incidence was 0.06% in acute leukemia patients in the Italian study.
- Literature search identified 177 cases; acute leukemia accounted for 71% of underlying conditions.
- An increase in cases was noted at M.D. Anderson Cancer Center, contrasting with stable rates elsewhere; cases are concentrated in the USA, France, and Italy.
Conclusions:
- Invasive fusariosis is a rare complication in hematological diseases, with no significant overall increase in the last 20 years.
- The epidemiological distribution of fusariosis is heterogeneous, with a need to consider local infection clusters.
- Awareness and vigilance for this deadly pathogen are crucial in specific geographic areas and patient populations.
Related Concept Videos
Fungal Phylum Microsporidia
Yellow Fever
Cryptococcal Meningitis
Malaria
American Trypanosomiasis
Amebiasis

